Norgine is working towards full compliance with Pharmaceutical Industry in Norway (LMI) and EFPIA requirements to report payments and transfers of value to healthcare professionals and healthcare organisations.

Please click on the following links to have a view of the recent transfers of value and our methodology for collecting the same.

Should you have any query related to the reported transfers of value, please contact us via contact details as listed towards the end of our methodology note.

Transfers of value: 2023, 2022, 2021

Methodology note: 2023, 2022, 2021

Patient Organisations/Donations: no interactions in 2023, 2022 or 2021.